ASSET PURCHASE AGREEMENT BY AND AMONG TETRALOGIC PHARMACEUTICALS CORPORATION, TETRALOGIC RESEARCH AND DEVELOPMENT CORPORATION AND MEDIVIR AB DATED AS OF NOVEMBER 2, 2016Asset Purchase Agreement • November 3rd, 2016 • Tetralogic Pharmaceuticals Corp • Pharmaceutical preparations • New York
Contract Type FiledNovember 3rd, 2016 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”) is made and entered into as of this 2nd day of November, 2016 by and among TetraLogic Pharmaceuticals Corporation, a Delaware corporation (“TLOG”), TetraLogic Research and Development Corporation, a Delaware corporation (“TR&D” and, collectively with TLOG, the “Sellers”), and Medivir AB, a Swedish corporation (the “Buyer”).